BIO-key International, Inc. (BKYI)
NASDAQ: BKYI · Real-Time Price · USD
4.450
-0.180 (-3.89%)
Apr 30, 2026, 1:15 PM EDT - Market open

BIO-key International Earnings Call Transcripts

Fiscal Year 2025

  • 2025 revenue declined due to contract timing and EMEA transition, but hardware and service revenues grew. Strong Q1 2026 guidance, improved margins, and new partnerships position the company for breakeven and profitability in early 2026.

  • Q3 2025 revenue was $1.5M, down year-over-year due to timing of large orders, but gross margin remained strong at 77%. Major banking and defense contracts are expanding, ARR is $6–$7M, and cost controls have reduced operating expenses by 8%.

  • Q2 2025 revenue grew 49% year-over-year, driven by hardware and service gains, while SG&A expenses fell 13.5%. Major defense and banking contracts in EMEA and Africa, plus new cyber defense initiatives, position the company for multi-year growth.

  • A leading provider of biometric authentication highlighted strong sequential revenue growth, global expansion, and new partnerships expected to drive millions in future revenue. The company is positioned for profitability in 2025, with a focus on high-margin, recurring revenue and expanding its presence in defense and technology sectors.

  • Q1 2025 saw 10% sequential revenue growth to $1.6M, strong gross margins, and a strengthened balance sheet. Key wins in defense, education, and EMEA, plus a major contract renewal, position the company for sequential growth and improved profitability in 2025.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Powered by